18F-FDG PET/CT in evaluation of squamous cell carcinoma.
Hell J Nucl Med
; 26(2): 99-107, 2023.
Article
em En
| MEDLINE
| ID: mdl-37527045
ABSTRACT
OBJECTIVE:
Squamous cell carcinomas (SCC) are a number of different types of cancer that result from squamous cells. These cells form on the surface of the skin, on the lining of the respiratory and digestive tracts etc. To evaluate SCC and frequencies of their localizations based on the findings of fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT). SUBJECTS ANDMETHODS:
This study included 343 consecutive patients with SCC who were sent for the 18F-FDG PET/CT. Inclusion criteria were Pathohistologically verified SCC; absence of malignancy of any other localization, as well as absence of infection; and glycemia ≤11mmol/L.RESULTS:
The pathological findings on 18F-FDG PET/CT were present in 86% of patients. There was statistically significant difference in the finding of 18F-FDG PET/CT in relation to gender (P>0.006). The disease was more often present in women. The most common localizations of disease were lungs (70%), vagina/cervix (18%), gastrointestinal tract (18%), head and neck (5%). Highest maximum standardized uptake value (SUVmax) levels were seen in the lungs 11.78±8.38, vagina/cervix 11.21±8.10, and head and neck area 6.32±3.96.CONCLUSION:
Fluorine-18-FDG PET/CT can be informative in evaluation of SCC. Disease is present usually in women, although it is the same pathohistological type of disease, different organs accumulate this radioactive contrast differently.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Carcinoma de Células Escamosas
/
Neoplasias de Cabeça e Pescoço
Limite:
Female
/
Humans
Idioma:
En
Revista:
Hell J Nucl Med
Ano de publicação:
2023
Tipo de documento:
Article